# ACTION AGAINST AGE-RELATED MACULAR DEGENERATION

## Details

- **Country:** England &amp; Wales
- **Charity number:** 1170224
- **Status:** Registered
- **Legal form:** CIO
- **Registered:** Nov. 16, 2016
- **Register:** https://register-of-charities.charitycommission.gov.uk/en/charity-search/?p_p_id=uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;_uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet_regId=1170224


## Contact

- **Address:** Action Against AMD, c/o Blind Veterans UK, 3 Queen Square, London
- **Postcode:** WC1N 3AR
- **Phone:** 0300 111 2233
- **Email:** joanna.zapisek@actionagainstamd.org
- **Website:** www.actionagainstamd.org



## Activities

**Objects:** FOR THE PUBLIC BENEFIT, THE ADVANCEMENT OF HEALTH BY RESEARCH INTO THE NATURE, CAUSES, DIAGNOSIS, PREVENTION, TREATMENT AND CURE OF AGE-RELATED MACULAR DEGENERATION, INCLUDING BUT NOT LIMITED TO THE DEVELOPMENT OF RESEARCH INTO PRACTICAL APPLICATIONS FOR THE PREVENTION, TREATMENT AND CURE OF AGE-RELATED MACULAR DEGENERATION.

**Activities:** ACTION AGAINST AGE RELATED MACULAR DEGENERATION (&#x27;AAAMD&#x27;) WILL FACILITATE FUND RAISING FOR BIOMEDICAL RESEARCH INTO THE TREATMENT OF AMD AND BE A DATA SOURCE OF RELATED INFORMATION. AAAMD  IS AN EQUAL COLLABORATION BETWEEN BLIND VETERANS UK, FIGHT FOR SIGHT, MACULAR SOCIETY AND THE SCOTTISH WAR BLINDED. THE EXISTING CHARITABLE ACTIVITIES OF THE FOUNDERS WILL CONTINUE ALONGSIDE AAAMD.




## Classification

- **How:** Sponsors Or Undertakes Research
- **What:** The Advancement Of Health Or Saving Of Lives, Disability
- **Who:** Elderly/old People



## Geography

- Northern Ireland
- Scotland
- Throughout England And Wales





## Trustees

| Name | Role | Appointed |
|---|---|---|
| **Mark O&#x27;Donnell** | Chair | May 6, 2022 |
| Adrian Bell |  | April 27, 2023 |
| CATHERINE MARY YELF |  | Nov. 16, 2016 |
| Craig Douglas Spalding |  | Feb. 22, 2022 |
| Dr Antonius Rijnders |  | Jan. 14, 2020 |
| Edward James Holloway |  | July 10, 2024 |




